Amoxicillin–clavulanic acid: Clinical Uses and Toxicity
Co-amoxiclav is widely used with good cure rates to treat urinary tract infections caused by both beta-lactamase-producing and nonproducing organisms, although in the latter case there is no advantage over amoxicillin alone.
Mar 18,2022
Amoxicillin–clavulanic acid: Antimicrobial Activity, Susceptibility, Administration and Dosage etc.
Amoxicillin–clavulanic acid (co-amoxiclav) is a combination product consisting of the semisynthetic antibiotic amoxicillin with the beta-lactamase inhibitor clavulanic acid as a potassium salt.
Mar 18,2022